Tanshinone IIA potentiates the efficacy of imatinib by regulating the AKT-MDM2-P53 signaling pathway in Philadelphia chromosome-positive acute lymphoblastic leukemia

Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is triggered by breakpoint cluster region-abelson leukemia virus (BCR/ABL) kinase. Targeting BCR/ABL kinase with tyrosine kinase inhibitors combined with chemotherapy is the standard first-line therapy for Ph+ ALL. Imatinib and...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yong, Wang, Fang-Fang, Xiang, Bing, Ma, Hong-Bing, Gong, Yu-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607239/
https://www.ncbi.nlm.nih.gov/pubmed/34820006
http://dx.doi.org/10.3892/ol.2021.13125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607239/
https://www.ncbi.nlm.nih.gov/pubmed/34820006
http://dx.doi.org/10.3892/ol.2021.13125

Ejemplares similares